Top Back to top

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Severe Aplastic Anaemia Working Party (SAAWP)
Study number:
8409077
Type of transplant:
 
Short title:
ATG in aPRCA
Study status:
 
Deadline for data collection:
 
Study design:
Retrospective study design
Primary objective:
To investigate the effectivity of treatment with ATG in patients with acquired PRCA.
Key inclusion criteria:
Patients are eligible if:
1) they have been diagnosed with acquired PRCA and
2) received ATG treatment between 2000 and 2018.
Country:
 
Principal investigator:
Stijn Halkes
Principal investigator email:
C.J.M.Halkes@lumc.nl
EBMT Study coordinator:
Brian Piepenbroek
Study coordinator email:
saawpebmt@lumc.nl